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Purpose: To investigate whether rutin retards selenite-induced cataractogenesis in Wistar rat pups.
Methods: On postpartum day ten, Group I rat pups received an intraperitoneal injection of saline. Group II and III rat
pups received a subcutaneous injection of sodium selenite. Group III also received an intraperitoneal injection of rutin
once daily on postpartum days 9–14. Both eyes of each pup were examined from day 16 up to postpartum day 30. After
sacriﬁce, extricated pup lenses were analyzed for mean activities of catalase, superoxide dismutase, glutathione peroxidase,
glutathione S-transferase, and glutathione reductase. In addition, the mean concentrations of reduced glutathione (GSH)
and of malondialdehyde were analyzed in samples of lenses and hemolysate.
Results: There was dense lenticular opaciﬁcation in all of Group II, minimal opaciﬁcation in 33.3% of Group III, no
opaciﬁcation in 66.7% of Group III, and no opaciﬁcation in Group I. Signiﬁcantly lower mean activities of lenticular
antioxidant enzymes were noted in Group II, compared to Group I and III. Significantly lower mean concentrations of
GSH and higher mean concentrations of malondialdehyde were noted in samples of hemolysate and lens from Group II,
compared to the values in Group I and III.
Conclusion: Rutin prevents experimental selenite-induced cataractogenesis in rat pups, possibly by preventing depletion
of antioxidant enzymes and of GSH, and by inhibiting lipid peroxidation.
Cataracts  are  the  most  common  cause  of  blindness
worldwide,  and  their  incidence  is  likely  to  increase  as
individuals  in  the  current  generation  grow  older  [1].
Currently,  surgery  is  the  mainstay  of  the  management  of
cataracts, but there continues to be a backlog in the services
provided in many parts of the world [2]. Delaying the onset
of cataracts by pharmacological means may help to bridge the
gap between the high incidence of cataract blindness and the
provision of surgical treatment. Various experimental models
have  been  used  to  study  the  etiology  of  cataracts  and  to
investigate different therapeutic modalities.
There is a large body of evidence implicating oxidative
stress  and  radical  oxygen  species  in  the  mechanism  of
cataractogenesis  [3,4].  The  selenite  cataract  is  a  rapidly
induced, convenient model for the study of senile nuclear
cataractogenesis [5]. Various compounds have been shown by
experimental  studies  to  prevent  selenite-induced
cataractogenesis,  including  resveratrol  [6],  melatonin  [7],
acetyl-L-carnitine [8,9], ellagic acid [10], soya bean [11],
extract  of  Pleurotus  ostreatus  [12],  L-cysteine  [13],  N-
acetylcysteine [14], and onion juice [15].
Mushrooms  constitute  an  integral  part  of  the  normal
human diet. They are considered valuable health foods, since
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they are low in calories, fats, and essential fatty acids, and high
in  vegetable  proteins,  vitamins,  and  minerals  [16,17].
Mushrooms reportedly contain relatively large amounts of
vitamins  A  and  C  and  of  β-carotene,  all  of  which  have
protective  effects  because  of  their  antioxidant  properties
[18]. Mushrooms also contain many phenols, which are very
efficient scavengers of peroxy radicals [18], and are reported
to  be  excellent  antioxidants  and  synergists  that  are  not
mutagenic [19].
We have previously shown that an ethanolic extract of
the  oyster  mushroom,  Pleurotus  ostreatus,  exerts  an
anticataractogenic  effect  in  an  animal  model  [12].
Interestingly, a high concentration of rutin (31.2 mg/100 g)
has been observed in P. ostreatus [20]. Rutin (quercetin-3-o-
β-rhamnosylglucose) is a flavone glycoside that is abundantly
present  in  herbs  and  plant  foods.  It  has  been  reported  to
scavenge free radicals, to lower hepatic and blood cholesterol
levels, and to exhibit antiplatelet activity [21,22]. In addition,
it has shown significant antioxidant activity in a liposomal
model reaction [23]. Nagasawa et al. [24] have also shown
that 0.2% of G-rutin (a rutin–glucose derivative), given in a
20% casein diet for a period of one month to streptozotocin-
induced diabetic rats, decreased thiobarbituric acid reactive
substance (TBARS) in kidneys. Therefore, we reasoned that
rutin possibly plays a major role in the anticataractogenic
effect of the ethanolic extract of P. ostreatus. This paper
describes an attempt to test this hypothesis in an experimental
model of selenite-induced cataractogenesis.
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Nine-day-old rat pups (Wistar strain) were used in this study.
The pups were housed with parents in large spacious cages,
and the parents were given food and water ad libitum. The
animal room was well ventilated, and a regular 12 h:12 h light-
dark  cycle  was  maintained  throughout  the  experimental
period.  These  animals  were  used  in  accordance  with
institutional guidelines and with the Association for Research
in  Vision  and  Ophthalmology  Statement  for  the  Use  of
Animals in Research. The rat pups were divided into one
control  group  and  two  experimental  groups,  each  group
comprising 12 pups:
1. Group I, which received only saline (control),
2. Group  II,  which  received  selenite  alone
(cataract-untreated), and
3. Group  III,  which  received  selenite  and  rutin
hydrate (cataract-treated).
Each  rat  pup  in  Groups  II  and  III  received  a  single
subcutaneous (s.c.) injection of sodium selenite (19 µmol/kg
body weight) on postpartum day ten. In addition, pups in
Group III received intraperitoneal (i.p.) injections (175 mg/kg
body weight) of rutin hydrate (Sigma Chemical Co., St. Louis,
MO). The ﬁrst dose of rutin was administered one day prior
to the selenite injection, and the rutin injection was repeated
once daily for ﬁve consecutive days thereafter.
Morphological examination of rat pup lenses: When the
rat pups ﬁrst opened their eyes (approximately 16 days after
birth), a slit-lamp biomicroscopic examination was performed
on  each  eye  of  each  rat  pup  to  provide  a  morphological
evaluation of any lenticular opaciﬁcation. Prior to performing
the examination, mydriasis was achieved by using a topical
ophthalmic  solution  containing  tropicamide  with
phenylephrine  (Maxdil  Plus,  Hi-Care  Pharma,  Chennai,
India). One drop of the solution was instilled every 30 min for
2 h into each eye of each rat pup, with the animals being kept
in a dark room. After 2 h, the eyes were viewed by a slit-lamp
biomicroscope  at  12×  magniﬁcation.  At  the  end  of  the
experimental  period  (postpartum  day  30),  the  degree  of
lenticular opaciﬁcation was graded and photographed. The
degree of opaciﬁcation was graded as follows:
0=normal transparent lens
+=initial  sign  of  nuclear  opacity  involving  tiny
scatters
++=partial nuclear opacity
+++=mature nuclear opacity
Biochemical analysis of lenses and blood samples from rat
pups:
Preparation  of  hemolysate  for  analysis—After
morphological examination on day 30, blood was drawn from
each rat pup in the three groups. From each blood sample,
serum  was  separated,  and  a  hemolysate  was  prepared
according to the procedure of Dodge et al. [25] as modified
by Quist [26]. Sample preparation was performed at 4 °C, and
all the samples were stored at −70 °C until analysis.
Preparation of lenses for analysis—After blood was
drawn from the rat pups, the animals were anaesthetized by
diethylether and then sacrificed by cervical dislocation. The
lenses were then removed by dissection. The lenses from each
group of rat pups were homogenized in ten times their mass
of  50  mM  phosphate  buffer  (pH  7.2),  and  centrifuged  at
12,000 rpm for 15 min at 4 °C. The supernatant obtained was
stored at −70 °C in aliquots until used for the analysis of
enzyme activities. To calculate the speciﬁc enzyme activity,
protein  in  each  sample  was  estimated  by  the  method  of
Bradford [27] by using bovine serum albumin as a standard.
Analysis of antioxidant enzymes:
Catalase—Catalase (CAT) activity was determined by
the method of Sinha [28]. In this test, dichromatic acetic acid
is reduced to chromic acetate when heated in the presence of
hydrogen peroxide (H2O2), with the formation of perchloric
acid as an unstable intermediate. In the test, the green color
developed  was  read  at  590  nm  against  blank  on  a
spectrophotometer. The activity of catalase was expressed as
units/mg protein (one unit was the amount of enzyme that
utilized 1 mmol of H2O2/min).
Superoxide dismutase—Superoxide dismutase (SOD)
activity  was  determined  by  the  method  of  Marklund  and
Marklund  [29].  In  this  test,  the  degree  of  inhibition  of
pyrogallol  auto-oxidation  by  the  supernatant  of  the  lens
homogenate was measured. The change in absorbance was
read at 470 nm against blank every 60 s for 3 min on a
spectrophotometer. The enzyme activity was expressed as
units/min/mg  protein  (one  unit  was  considered  to  be  the
amount of enzyme that inhibited pyrogallol auto-oxidation by
50%).
Glutathione  peroxidase—The  activity  of  glutathione
peroxidase (Gpx) was determined essentially as described by
Rotruck et al. [30]. The principle of this method is that the rate
of glutathione oxidation by H2O2, as catalyzed by the Gpx
present in the supernatant, is determined, and the color that
develops  is  read  against  a  reagent  blank  at  412  nm  on  a
spectrophotometer.  In  the  test,  the  enzyme  activity  was
expressed as units/mg protein (one unit was the amount of
enzyme that converted 1 µmol of reduced glutathione [GSH]
to the oxidized form of glutathione [GSSH] in the presence of
H2O2/min).
Glutathione  reductase—This  enzyme  glutathione
reductase  (GR),  which  utilizes  nicotinamide  adenine
dinucleotide  phosphate  (NADPH)  to  convert  oxidized
glutathione to its reduced form, was assayed by the method of
Stall et al. [31]. The change in absorbance was read at 340 nm
for  2  min  at  intervals  of  30  seconds  in  a  UV-
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expressed as nmol of NADPH oxidized/min/mg protein.
Glutathione  S-Transferase—The  activity  of
glutathione  S-transferase  (GST)was  determined  by  the
method of Habig and Jacoby [32]. The conjugation of GSH
with  1  chloro,  2-4  dinitrobenzene  (CDNB),  a  hydrophilic
substrate, was observed spectrophotometrically at 340 nm to
measure the activity of GST; one unit of GST was defined as
the amount of enzyme required to conjugate 1 μmol of CDNB
with GSH/min.
Estimation of reduced glutathione and malondialdehyde
content  in  lenses  and  hemolysate:  The  GSH  content  was
estimated by the method of Moron et al. [33]. Each lens was
homogenized in 1 ml of 0.1 M phosphate buffer, and was
centrifuged at 5,000 rpm for 15 min at 4 °C. To the supernatant
of  the  lenticular  homogenate  or  hemolysate,  10%
trichloroacetic  acid  (0.5  ml)  was  added,  followed  by
recentrifugation. To the protein-free supernatant, 4 ml of 0.3
M  Na2HPO4  (pH  8.0)  and  0.5  ml  of  0.04%  (wt/vol)  5,5-
dithiobis-2-nitrobenzoic acid were added. The absorbance of
the resulting yellow color was read spectrophotometrically at
412 nm. A parallel standard was also maintained. The results
were  expressed  in  µmol/g  wet  weight  for  the  lenses  and
nmoles/g hemoglobin (Hb) for hemolysate.
The extent of lipid peroxidation was determined by the
method of Ohkawa et al. [34]. Briefly, 0.2 ml of 8.1% sodium
dodecyl sulphate, 1.5 ml of 20% acetic acid (pH 3.5), and 1.5
ml of 0.81% thiobarbituric acid aqueous solution were added
in succession. To this reaction mixture, 0.2 ml of the tissue
sample (lenticular homogenate or hemolysate) were added.
The mixture was then heated in boiling water for 60 min. After
cooling to room temperature, 5 ml of butanol:pyridine (15:1
v/v) solution were added. The mixture was then centrifuged
at  5,000  rpm  for  15  min.  The  upper  organic  layer  was
separated, and the intensity of the resulting pink color was
read at 532 nm. Tetramethoxypropane was used as an external
standard. The level of lipid peroxide was expressed as nmoles
of MDA formed/g wet weight for lenses, and nmoles of MDA
formed/g Hb for hemolysate.
Statistical analysis: The values are expressed as the mean
±SD for the 12 pups in each group. Differences between
groups  were  assessed  by  one-way  analysis  of  variance
(ANOVA) using the Statistical Package for Social Sciences
(SPSS) software package for Windows (version 16.0). Post
hoc testing was performed for intergroup comparisons using
the least significant difference (LSD) test, and the chi-square
test was applied wherever relevant. A value corresponding to
p<0.05 was deemed to be statistically significant.
RESULTS
Morphological  examination  to  determine  lenticular
opacification in rat pups: Morphological examination of both
eyes of each rat pup was done by slit-lamp examination on the
30th  day  after  birth.  All  12  rat  pups  in  Group  II  (which
received s.c. injections of sodium selenite) exhibited dense
opacification of the lenses (grade +++ opacity). In contrast,
only 4 of 12 (33.3%) rat pups in Group III (which received
i.p. injections of rutin hydrate, along with sodium selenite)
exhibited mild lenticular opacification (grade +), with the
lenses of the other eight pups appearing normal (grade 0). All
12 rat pups in Group I (which received normal saline as the
control) exhibited complete transparency (grade 0) of the lens
(Figure 1, Table 1). The difference between the percentages
of Group II and of Group III exhibiting lenticular opacification
was statistically significant (χ2 [ degree of freedom=1]=4.0;
p<0.05).
Results of biochemical analysis:
Catalase—The  mean  activity  of  CAT  (expressed  as
mmol H2O2 consumed/min/mg protein) in lenses of Group II
(3.77±0.36)  was  significantly  (p<0.05)  lower  than  that  in
lenses of Group I (7.37±0.87) and that in lenses of Group III
(6.36±0.52). The mean catalase activity in the lenses of Group
III was significantly (p<0.05) lower than that in Group I rat
lenses (Table 2).
Figure 1. Slit-lamp appearance of lenses in eyes of 16-day-old Wistar rat pups. A: Lenses in normal (Group I) pup eyes have all remained
transparent (grade 0 opacity). B: Lenses in cataract-untreated (Group II) eyes have all become densely opaque (grade +++ opacity). C: Lenses
in some cataract-treated (Group III) pup eyes have become mildly opaque (grade + opacity).
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(expressed as units/min/mg protein) in Group II rat lenses
(1.95±0.62)  was  significantly  (p<0.05)  lower  than  that  in
lenses of Group I (2.99±0.64) and that in lenses of Group III
(2.11±0.79). The mean activity of SOD in lenses of Group III
was significantly (p<0.05) lower than that in Group I rat lenses
(Table 2).
Glutathione  peroxidase—The  mean  activity  of  Gpx
enzyme  (expressed  as  µmol  glutathione  oxidized/min/mg
protein)  was  significantly  (p<0.05)  lower  in  Group  II
(27.55±8.79)  lenses  than  that  in  lenses  of  Group  I
(37.72±7.03) and Group III (28.82±7.79). The mean activity
of Gpx in Group III rat lenses was significantly (p<0.05) lower
than that in lenses of Group I (Table 2).
Glutathione S-Transferase—The mean activity of GST
(expressed as µmol of CDNB conjugate with GSH/min) was
significantly (p<0.05) lower in Group II (3.60±0.42) rat lenses
than that in lenses of Group I (5.86±0.75) and Group III
(4.73±0.72). The mean activity of GST in Group III rat lenses
was significantly (p<0.05) lower than that in Group I rat lenses
(Table 2).
Glutathione  reductase—The  mean  activity  of  GR
(expressed as nmol of NADPH oxidized/min/mg protein) was
significantly lower (p<0.05) in Group II rat lenses (0.23±0.02)
than that in Group I rat lenses (0.29±0.03) and Group III rat
lenses (0.27±0.01). However, no significant differences were
observed between the mean activity of GR in lenses of Group
I and Group III (Table 2).
Effect on reduced glutathione and malondialdehyde levels in
hemolysate and lenses: The mean GSH levels in hemolysate
(446.98±48)  and  lenses  (5.22±0.29)  of  Group  II  were
significantly (p<0.05) lower than that in Group I(hemolysate
[782.01±89] and lens [8.39±0.56]) and Group III (hemolysate
[678.84±85] and lens [7.33±0.87]). The mean GSH levels in
hemolysate  and  lenses  of  Group  III  were  significantly
(p<0.05)  lower  than  the  corresponding  values  in  Group  I
(Table 3).
The  mean  concentrations  of  MDA  in  hemolysate
(384.2±70)  and  lenses  (90.29±5.08)  of  Group  II  were
significantly (p<0.05) greater than the mean concentrations in
Group I (hemolysate [286.88±84] and lens [60.13±7.94]) and
Group III (hemolysate [307.09±57] and lens [74.23±12.52]).
The mean concentrations of MDA in hemolysate and lenses
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TABLE 1. MORPHOLOGICAL EXAMINATION OF LENSES OF RAT PUPS.
Experimental
groups
Number of
pups
Number of pups with different
degrees of lenticular opacification
Number of
pups in
which
lenticular
opacification
occurred 0 + ++ +++
Group I (normal) 12 12 - - - 0
Group II (cataract-
untreated)
12 - - - 12 all 12 (100%)
Group III (cataract-
treated)
12 8 4 - - 4 of 12 (33.3%)
Group I rat pups received only saline; Group II rat pups received only selenite; Group III rat pups received selenite and rutin
hydrate. The degree of opaciﬁcation was graded as follows: 0 = normal transparent lens; + = initial sign of nuclear opacity
involving tiny scatters; ++ = partial nuclear opacity; +++ = mature nuclear opacity.
TABLE 2. ACTIVITIES OF ANTIOXIDANT ENZYMES IN LENTICULAR SAMPLES FROM RAT PUPS.
Enzymes (unit of activity)
Group I
(Normal)
Group II
(cataract-
untreated)
Group III
(cataract-
treated)
Catalase (mmol H2O2 consumed/min/mg protein) 7.37±0.87 3.77±0.36a,b 6.36±0.52a
Superoxide dismutase (unit/min/mg protein) 2.99±0.64 1.95±0.62a,b 2.11±0.79a
Glutathione peroxidase (µmol glutathione oxidized/min/mg protein) 37.72±7.03 27.55±8.79a,b 28.82±7.79a
Glutathione-S-transferase (µmol of CDNB conjugate with GSH/min/mg
protein)
5.86±0.75 3.60±0.42a,b 4.73±0.72a
Glutathione reductase (nmoles of NADPH oxidized/min/mg protein) 0.29±0.03 0.23±0.02a.b 0.27±0.01NS
All values are expressed as mean ± SD of six determinations. Group I: Rat pups received only saline. Group II: Rat pups received
only selenite. Group III: Rat pups received selenite and rutin hydrate. aValue significantly different (p<0.05) from Group I value.
bValue significantly different (p<0.05) from Group III value.of Group III were significantly (p<0.05) greater than that in
Group I (Table 4).
DISCUSSION
Currently, surgical removal of the opaque lens is the standard
treatment for human cataracts; however, because the number
of individuals who require surgery far exceeds the number of
operations  being  performed,  attempts  have  been  made  to
develop molecules that prevent or delay formation of senile
cataracts. Human cataracts are the result of a multifactorial
disease associated with several risk factors. Oxidative stress
is  believed  to  play  a  key  role  in  cataractogenesis,  and
augmentation of the antioxidant defenses of the lens has been
shown to prevent or delay experimental cataracts [3].
Protection of the lens from oxidative damage, and hence
maintenance  of  transparency,  is  afforded  by  antioxidant
systems  that  consist  of  non-enzymatic  and  enzymatic
components.  Human  senile  or  experimental  cataract
formation  is  associated  with  a  progressive  decrease  in
lenticular GSH [35,36]. Therefore, it has been suggested that
GSH  plays  an  important  role  in  maintaining  lenticular
function and transparency by protecting sulfhydryl groups
from oxidation [37,38]. The putative importance of oxidative
stress in the pathogenesis of cataracts, and in aging in general,
has focused attention on antioxidant nutrients.
We have previously reported that an ethanolic extract of
the  oyster  mushroom  P.  ostreatus,  could  prevent
cataractogenesis  in  an  animal  model  of  selenite-induced
cataracts. A comparatively high content of chrysin (40 mg/
100 g) and rutin (31.2 mg/100 g) was recently observed in an
ethanolic extract of P. ostreatus, and the authors suggested
that these flavonoids possibly contributed to the antioxidant
activity of the extract [20]. Rutin modulates a number of
biological functions, and exhibits anti-inflammatory and anti-
microbial activities [39]. The ability of rutin to scavenge free
radicals and to inhibit lipid peroxidation has been reported in
conditions of streptozotocin-induced oxidative stress [40]. In
addition, rutin has also been reported to play a positive role in
carbohydrate metabolism [41], and to elevate the antioxidant
status in diabetic rats [42].
In the present study, the observations made by gross
morphological examination of the lenses in 30-day-old Wistar
rat pups appear to suggest that rutin is able to significantly
retard selenite-induced cataractogenesis in these animals. At
the end of the study period, all the rat pups that had received
only selenite (Group II) were found to have developed a dense
nuclear opacity in the lens of each eye, whereas only 33.3%
of pups that had received selenite and been treated with rutin
(Group III) were found to have mild lenticular opacification
in each eye (Table 1; Figure 1A-C). The other 66.7% of pups
in that group had clear lenses in both eyes, as in normal pups
(Group I).
Antioxidant enzymes are able to catalytically remove free
radicals and other reactive species. A wide array of enzymatic
antioxidant defenses exists, including SOD, CAT, and Gpx.
Superoxide dismutases are present in all eye tissues [43] and
are specific for catalytic removal of superoxide. SOD converts
superoxide  to  H2O2.  CAT  catalyzes  the  two-electron
Molecular Vision 2009; 15:2570-2577 <http://www.molvis.org/molvis/v15/a275> © 2009 Molecular Vision
2574
TABLE 3. MEAN LEVEL OF REDUCED GLUTATHIONE IN SAMPLES OF HEMOLYSATE AND LENSES FROM RAT PUPS.
Groups GSH in hemolysate (nmoles/g Hb) GSH in lenses (µmoles/g wet weight)
Group I 782.01±79 8.39±0.56
Group II 446.98±48
a,b 5.22±0.29
a,b
GroupIII 678.84±67
a 7.33±0.45
a
All values are expressed as mean ±SD of six determinations. Group I: Rat pups received only saline. Group II: Rat pups received
only selenite. Group III: Rat pups received selenite and rutin hydrate. In the table, GSH represents reduced glutathione and Hb
represents hemoglobin. aValue significantly different (p<0.05) from Group I value. bValue significantly different (p<0.05) from
Group III value.
TABLE 4. MEAN CONCENTRATION OF MALONDIALDEHYDE IN SAMPLES OF HEMOLYSATE AND LENSES FROM RAT PUPS.
Groups MDA in hemolysate (nmoles/g Hb) MDA in lenses (nmoles/g wet weight)
Group I 286.88±84 61.23±2.94
Group II 382.79±50
a,b 90.29±3.08
a,b
Group III 337.09±72
a 74.23±1.92
b
All values are expressed as mean ±SD of six determinations. Group I: Rat pups received only saline. Group II: Rat pups received
only selenite. Group III: Rat pups received selenite and rutin hydrate. In the table, MDA represents malondialdehyde and Hb
represents hemoglobin. aValue significantly different (p<0.05) from Group I value. bValue significantly different (p<0.05) from
Group III value.dismutation of hydrogen peroxide into ground-state oxygen
and water. Gpx and CAT are present in all parts of the eye.
Gpx is the predominant GSH-consuming enzyme and the Gpx
family uses GSH as a cofactor to destroy hydrogen peroxide
and  lipoperoxides.  Glutathione  reductase  is  the  rate-
controlling enzyme of the glutathione redox cycle [44], and
the  intracellular  level  of  GSH  is  maintained  by  GR  by
preserving the integrity of cell membranes and by stabilizing
the  sulfhydryl  groups  of  proteins  [45].  Glutathione  S-
transferases are a typical multifunctional enzyme, which plays
a role in the hydrophobic compounds as a thioltransferase-like
redox regulator [46].
In the present study, the mean activities of CAT, SOD,
Gpx, GST, and GR were found to be significantly lower in the
lenses of cataract-untreated (Group II) rat pups than that in
normal  control  (Group  I)  rat  lenses  (Table  2).  Lowered
activities  of  these  enzymes  in  selenite-induced
cataractogenesis  have  been  well-documented  in  in  vivo
experimental animal models [9-11,47]. However, in lenses
treated  with  rutin  hydrate  in  the  present  study,  the  mean
activities of antioxidant enzymes were significantly higher
than the values in rat pups with untreated cataracts (Table 2).
GSH,  a  ubiquitous  essential  tripeptide  thiol  (L-γ-
glutamyl-L-cysteinyl-glycine),  is  a  vital  intra-  and  extra-
cellular  protective  antioxidant  against  oxidative  stress.  It
contains a side chain sulfhydryl (-SH) residue that enables it
to protect cells against oxidants [48]. Therefore, maintenance
of GSH is known to be vital for lenticular transparency. In the
present  study,  the  mean  level  of  GSH  was  found  to  be
significantly lower in the lenses of cataract-untreated (Group
II) rat pups than that in normal (Group I) rat lenses (Table 3).
A progressive decrease of GSH in the lens has been found to
be associated with experimental cataract formation or human
senile cataract formation [35,36]. A depletion in GSH content
in post-mitotic tissues has also been found to occur during
aging, possibly due to enhanced oxidative damage due to free
radicals [49]. In the lenses of cataract-treated rat pups (Group
III) in the present study, the mean level of GSH was found to
be increased (relative to Group II rat lenses; Table 3), with an
accompanying increase in the mean activities of GR and GST.
Lipid peroxidation is a free-radical mediated propagation
of oxidative insult to polyunsaturated fatty acids, involving
several  types  of  free  radicals;  termination  occurs  through
enzymatic  means  or  by  free  radical  scavenging  by
antioxidants [50]. Increased lenticular MDA may be the result
of  increased  lipid  peroxidation  of  the  lenticular  cell
membranes, or may represent the consequence of migration
of MDA from the readily peroxidizable retina or from the
central  body  compartment  [51-55].  In  the  present
investigation, such a disruption of membrane lipids possibly
accounted for the observed increase in MDA levels in the
lenses  of  cataract-untreated  (Group  II)  rat  pups  when
compared  to  normal  (Group  I)  rat  pups  (Table  4).  The
observed  lower  mean  MDA  level  in  the  cataract-treated
(Group III) group (relative to Group II values) suggests that
rutin hydrate possibly preserved the structural integrity of the
lens, thereby preventing lenticular opacification. These data
corroborate the findings of earlier investigators [9,10,14].
From the results obtained, it appears that rutin prevents
selenite-induced  cataractogenesis  in  Wistar  rat  pups.
Morphological assessment showed that the damage caused by
selenite-induced  cataractogenesis  was  attenuated  by  the
administration of rutin. The results of biochemical evaluation
suggest that rutin prevents cataractogenesis by enhancing the
activities of antioxidant enzymes and functions of the redox
system, and by reducing the extent of lipid peroxidation.
A  question  may  arise  regarding  the  relevance  of  the
results of the present study, done in Wistar rats, to the situation
in humans. In this context, the following points should be
considered.  In  a  study  on  the  intake  of  flavonoids  and
isoflavonoids in volunteer Japanese women, the average daily
intake of rutin was found to be 1.5 mg and that of quercetin
(closely related to of rutin) was 8.3 mg [56]; vegetables in the
diet were the major source. While this level of intake may
seem low, it is important to note that dietary supplements of
rutin  are  commercially  available  as  500  mg  tablets  and
capsules [57]; the recommended dosage of these supplements
is 500 mg taken once or twice daily. Interestingly Boyle et al.
[58] reported that when 500 mg rutin supplementation was
given daily for 6 weeks to human volunteers, it did not induce
any adverse changes in blood chemistry or indices of liver
function.  Thus,  oral  intake  of  500  mg  of  rutin  (as  a
supplementary  tablet  or  capsule)  per  day  possibly
approximates the intraperitoneal dosage of rutin used in the
present study in Wistar rat pups (175 mg/kg body weight per
day), although pharmacokinetic studies would be needed to
definitively confirm this.
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